Fund HoldingsJOHNSON & JOHNSON

Total Portfolio Value
$334.10M
Total Bought
$0
Total Sold
$74.9K
Net Transaction
-$74.9K
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
Protagonist Therapeutics Inc.2,449,1832,449,1830118,442136,39540.83%+17,953
Nanobiotix S.A.(NBTX)5,623,8165,623,816020,13325,4557.62%+5,321
Rapport Therapeutics, Inc.(RAPP)2,498,0512,498,051025,05528,5538.55%+3,497
Fate Therapeutics, Inc.3,379,0643,379,06402,6703,5141.05%+844
Arrowhead Pharmaceuticals, Inc.(ARWR)247,598247,59803,1543,9811.19%+827
Legend Biotech Corporation(LEGN)814,586814,586027,63928,2098.44%+570
Vor Biopharma, Inc.(VOR)1,074,6581,074,65807711,1390.34%+368
Nano-X Imaging Ltd.
ORD SHS
158,852158,85207938310.25%+37
Standard BioTools Inc311,967311,96703373710.11%+34
Senseonics Holdings, Inc.54,62154,621036270.01%-9
BiomX Inc.96,86696,866054430.01%-11
Adicet Bio, Inc.364,472364,47202752280.07%-47
Lyell Immunopharma Inc.823,31741,165-782,1524433680.11%-75
Neumora Therapeutics, Inc.1,849,4451,849,44501,8491,4000.42%-450
Procept BioRobotics Corporation(PRCT)357,939357,939020,85420,3706.10%-483
MeiraGTx Holdings plc(MGTX)6,641,0646,641,064045,02643,89713.14%-1,129
Rallybio Corporation3,636,3633,636,36302,3801,2090.36%-1,171
Xencor, Inc.(XNCR)748,062748,06207,9596,0891.82%-1,870
Contineum Therapeutics Inc.1,979,1731,979,173013,8158,1342.43%-5,680
CVRx, Inc.4,103,4304,103,430050,18523,8827.15%-26,303
Page 1 of 1